Podcasts about clinical operations

In this episode of Behind the Knife, the minimally invasive surgery (MIS) team dives deep into the evolving field of common bile duct exploration (CBDE). From the historical context of laparoscopic approaches to the latest advances including robotic-assisted techniques, Drs. Shaina Eckhouse, James Jung, Zachary Weitzner, and Joey Lew discuss key evidence shaping modern practice. Listeners will learn about indications and anatomy guiding trans-cystic versus trans-choledochal approaches, practical tips for safe stone clearance, and critical considerations around learning curves and team coordination for robotic procedures. The episode also highlights important studies comparing single-stage laparoscopic CBDE with staged ERCP and cholecystectomy, emphasizing outcomes such as stone clearance, pancreatitis rates, and hospital length of stay. This comprehensive overview is a must-listen for MIS and acute care surgeons interested in optimizing the management of choledocholithiasis and streamlining patient care with minimally invasive techniques. Hosts:  - Shaina Eckhouse, MD, Bariatric Surgery Medical Director and Vice Chair of Clinical Operations, Department of Surgery, Duke University - James Jung, MD, PhD, Assistant Professor of Surgery, Duke University - Zachary Weitzner, MD, Minimally Invasive and Bariatric Surgery Fellow, Duke University, @ZachWeitznerMD - Joey Lew, MD, MFA, Surgical resident PGY-3, Duke University, @lew__actually Learning Goals:  By the end of this episode, listeners will be able to: -  Describe the historical approaches to managing choledocholithiasis, including staged interventions and the evolution toward single-stage laparoscopic common bile duct exploration (CBDE). -  Summarize key clinical evidence comparing CBDE and ERCP, including landmark studies and meta-analyses evaluating outcomes, complications, and trends over time.​ - Distinguish between transcystic and transcholedochal approaches to CBDE, explaining indications, contraindications, and technical nuances for each technique.​ -  Identify appropriate candidates for transcystic exploration based on cystic duct anatomy and stone characteristics.​ - Recognize the impact of newer surgical technologies—such as digital choledochoscopy, Spyglass, and robotic platforms—on CBDE practice, efficiency, and safety.​ - Discuss the importance of multidisciplinary teamwork, preparation, and perioperative planning for successful CBDE, particularly in complex or altered anatomy cases.​​ - Appraise the learning curve and quality of evidence for new CBDE procedures, outlining the need for mentorship, ongoing training, and knowing when to collaborate with GI or hepatopancreaticobiliary (HPB) surgery.​ - Outline approaches and bailout strategies for challenging cases, including patients with surgically altered anatomy and use of adjuncts such as intraoperative cholangiography (IOC), feeding tube placement, and Fanelli stents.​​ - Evaluate safety outcomes and limitations associated with robotic-assisted CBDE and single-stage management, incorporating recent data from population-based studies.​ -  Reflect on strategies for tailoring CBDE techniques to individual patient anatomy, surgeon experience, and available resources, advocating for evidence-based practice and continuous learning. References: -  Giurgiu DI, Margulies DR, Carroll BJ, et al. Laparoscopic Common Bile Duct Exploration: Long-term Outcome. Arch Surg. 1999;134(8):839-844. doi:10.1001/archsurg.134.8.839 https://pubmed.ncbi.nlm.nih.gov/10443806/ -  Lyu Y, Cheng Y, Li T, Cheng B, Jin X. Laparoscopic common bile duct exploration plus cholecystectomy versus endoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomy for cholecystocholedocholithiasis: a meta-analysis. Surg Endosc. 2019;33(10):3275-3286. doi:10.1007/s00464-018-06613-w https://pubmed.ncbi.nlm.nih.gov/30511313/ - Bekheit M, Smith R, Ramsay G, Soggiu F, Ghazanfar M, Ahmed I. Meta‐analysis of laparoscopic transcystic versus transcholedochal common bile duct exploration for choledocholithiasis. BJS Open. 2019;3(3):242-251. doi:10.1002/bjs5.50132 https://pubmed.ncbi.nlm.nih.gov/31183439/ - Cironi K, Martin MJ. Reclaim the duct! Laparoscopic common bile duct exploration for the acute care surgeon. Trauma Surg Acute Care Open. 2025;10(Suppl 1). doi:10.1136/tsaco-2025-001821 https://pubmed.ncbi.nlm.nih.gov/40255986/ - Zhang C, Cheung DC, Johnson E, et al. Robotic Common Bile Duct Exploration for Choledocholithiasis. JSLS J Soc Laparosc Robot Surg. 2025;29(1):e2024.00075. doi:10.4293/JSLS.2024.00075 https://pubmed.ncbi.nlm.nih.gov/40144383/ - Kalata S, Thumma JR, Norton EC, Dimick JB, Sheetz KH. Comparative Safety of Robotic-Assisted vs Laparoscopic Cholecystectomy. JAMA Surg. 2023;158(12):1303-1310. doi:10.1001/jamasurg.2023.4389 https://pubmed.ncbi.nlm.nih.gov/37728932/ Ad Disclosure: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only  Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

In a collaborative podcast with the American Psychosocial Oncology Society hosted by Daniel C. McFarland, DO, guests Louis P. Voigt, MD, and Yesne Alici, MD, discussed the ethical and clinical complexities of assessing decision-making capacity (DMC) in oncology, emphasizing its role as the ethical core of person-centered care. The discussion began by dissecting modern medicine's need for formal DMC assessment. Voigt framed DMC as a fundamental issue of patient rights and respect, asserting that every human being has absolute rights and that the integrity of a person requires honoring their self-determination. He advocated for clinicians to act as professionals, earn trust, customize their approach based on individual needs through precision medicine, and demonstrate humility by re-explaining information when a patient cannot summarize their understanding. Alici provided a detailed clinical framework for DMC, defining it as a person's ability to decide on the specific issue at hand while appreciating the foreseeable consequences. She outlined the 4 key elements, or pillars, of the assessment: the patient's ability to understand the information, to appreciate the risks and benefits, to provide a rationalization for the decision to ensure no delusional thinking interferes, and to communicate a consistent choice. She clarified that DMC is decision-specific and time-dependent, emphasizing that conditions like dementia, schizophrenia, major depression, or even a central nervous system malignancy do not automatically mean a patient lacks capacity; it must be assessed for each situation and may be restored if cases like delirium are reversible. She cautioned that clinicians must be mindful of potential mislabeling when patients with aphasia interact, as simple gestures may not fully represent informed consent. Finally, the experts addressed the crucial implications that follow an assessment of incapacity. Voigt highlighted that a lack of DMC is not a "stop sign"; decisions must still be made, requiring the health care team to look to a designated proxy or the patient's next-of-kin. He stressed the need for hospitals to establish system-wide processes and workflows to prepare all stakeholders for these contingencies and help patients become familiar with advanced directives, thereby reducing the immense emotional burden placed on surrogates who must perform substituted judgment. McFarland concluded that being aware of DMC elevates the quality of care, reinforces an ethical climate, and enhances the entire organization. McFarland is the director of the Psycho-Oncology Program at Wilmot Cancer Center and a medical oncologist who specializes in head, neck, and lung cancer, in addition to being a psycho-oncology editorial advisory board member for the journal ONCOLOGY. Voigt is an intensivist and chair of the Ethics Committee at Memorial Sloan Kettering Cancer Center (MSKCC). Alici is vice chair of Clinical Operations in the Department of Psychiatry and Behavioral Sciences, clinical director, associate attending psychiatrist, and medical director of the Biobehavioral Health Clinic at MSKCC. 

The FDA Group's Nick Capman sits down with Maria Vassileva, PhD—Chief Science & Regulatory Officer at the Drug Information Association (DIA)—for a grounded, forward-looking discussion on how regulators are actually using AI today, where the technology is going, and what life science organizations should be preparing for now.Maria draws on two decades of leadership across nonprofit, government-funded clinical research, and biomedical science programs—spanning patient registries, clinical trials, multi-stakeholder consortia, DEI initiatives, and regulatory strategy. As the head of DIA's global science and regulatory portfolio, she works closely with regulators, industry sponsors, academia, and technology developers to advance responsible, evidence-driven innovation.In this conversation, Maria breaks down the reality behind AI in the regulatory ecosystem: what's currently in use, how agencies are evaluating and validating tools, why risk-based tiers matter, and how the field is moving toward lifecycle oversight rather than one-time checks. She also highlights the ethical and equity considerations that must be embedded from the start and shares insights from global regulatory trends and DIA's convening role.Key topics discussed include:How regulatory agencies are already using AI internally for document-heavy workflows, safety surveillance, and information retrievalWhy validation must focus on end-to-end workflow integrity, not just the modelThe emerging role of risk-based tiers for AI-enabled toolsThe importance of lifecycle control frameworks such as TPLC and PCCPsGlobal convergence themes around transparency, bias mitigation, and human accountabilityHow agencies are preparing for increasing AI adoption—and what industry teams should be doing nowDIA's role as a neutral convener helping harmonize expectations and accelerate responsible innovationAbout The FDA GroupThe FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations: https://www.thefdagroup.com/

Coruna Medical's Vice President of Quality, Jeff Hines, joins host Nick Capman to share a leadership-driven playbook for navigating FDA remediation—without overwhelming teams or losing focus on long-term improvement.Drawing from nearly four decades in pharmaceutical quality, including more than 30 years at Eli Lilly, Jeff offers practical guidance for building calm, effective inspection environments and keeping people confident under pressure. He outlines the four-room model for inspection management, strategies for responding to observations, and proven methods for closing data-integrity gaps while daily operations continue.Jeff and Nick also explore the leadership mindset that sustains progress beyond the initial response—fostering transparency, prioritization, and a culture of accountability that prevents repeat findings.Topics discussed include:The leadership posture that steadies teams during inspections and remediationHow to stand up the four-room inspection model (Front, Back, Doc-QC, SME-Prep)Responding to 483s: when to push, when to accept, and how to align internallyData-integrity vulnerabilities and effective interim controlsBalancing remediation with production demandsBuilding transparency and accountability into quality cultureKeeping systems current to avoid backsliding into repeat observationsAbout The FDA GroupThe FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations: ⁠https://www.thefdagroup.com/

In this episode of What's Best For The Patient Is Best For Business, Jerry sits down with Lissa Taitano, Director of Clinical Operations for Livara Health. Livara is a purpose-built musculoskeletal (MSK) management solution that combines care planning, delivery, and navigation to create a more connected healthcare system.Lissa, a physical therapist by training with over 15 years of experience in value-based care, pulls back the curtain on how a truly patient-centric model delivers superior outcomes for both people and businesses. She details Livara's journey from a local clinic to a national leader, explaining how integrating a holistic, biopsychosocial approach—including physical therapy, pain reprocessing therapy, nutrition, and health coaching—led to patients getting "100% better, faster" while simultaneously reducing costs and surgical utilization.This conversation is a masterclass in the future of MSK care. Jerry and Lissa tackle the tough questions every practice owner needs to ask, challenging the unsustainable fee-for-service status quo and outlining the essential mindset shift required to thrive.Key Takeaways:• Why the traditional, fragmented model is failing MSK patients and how a "quarterback" approach creates central accountability and a seamless patient journey.• The power of a holistic, biopsychosocial model: Discover how addressing contextual drivers like stress, nutrition, and mental health is the key to unlocking better outcomes and preventing chronic pain cycles.• How to build a powerful patient engagement strategy that extends beyond episodic clinic visits, using technology and personalized communication to meet patients where they are.• The business case for value-based care: Learn how proactive, high-engagement models lead to dramatically lower costs (35-45%), reduced surgical utilization (40-53%), and higher patient satisfaction.• The two things clinic owners must do today to prepare for the future: Collect and leverage your clinical outcome data, and be open-minded about changing your business model to prioritize value over volume.Tune in for an inspiring and practical look at how getting upstream, owning the patient's entire MSK journey, and focusing on what's truly best for the patient is, unequivocally, the best path forward for business. If you'd like to learn more about Strata EMR & RCM and achieving a 99.99% reimbursement rate for your PT, OT, or SLP Clinic head over to stratapt.com and book a demo with their team!

The FDA Group's Nick Capman speaks with Marwan Fathallah, President and CEO of DIA Global, for a wide-ranging discussion on what it takes to lead effectively across the life science product development cycle—from concept to commercialization.With nearly 30 years of leadership experience spanning pharmaceuticals, medical devices, and diagnostics, Marwan has held senior roles in R&D, regulatory, clinical, scientific affairs, and operations. He brings a rare, holistic view of how leadership, culture, and systems thinking come together to drive successful outcomes in complex, regulated environments.Their conversation explores how to balance innovation and compliance, structure cross-functional teams for consistent execution, and foster cultures that prioritize transparency, collaboration, and patient focus.About The FDA GroupThe FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle—from clinical development to commercialization—with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations: https://www.thefdagroup.com/

Many healthcare organizations know they need an outpatient CDI program, but are tripped up by the most fundamental question: What is the expected return on investment after a considerable upfront investment of time, human capital, training, and technology? Discover the tangible impact of outpatient CDI on revenue, risk capture, provider alignment, and compliance in this special session of Off the Record. Jason Jobes, Senior Vice President, Solutions, Norwood, and Carol Ann Hudson, AVP of Quality and Clinical Operations and Population Health for Lifepoint Health first presented this popular session at the ACDIS 2026 national conference and later for a select virtual audience, and I'm pleased to bring it to my listeners. You'll walk away with a big picture understanding of OP CDI and concrete, operational strategies for transforming your program. If you haven't started yet, consider this your blueprint. Note that “ROI” doesn't only equate to revenue. Return on investment can also come in the form of denials resistant documentation, coding compliance, and improved patient care and value based care alignment through a greater emphasis on patient scheduling. All of which Lifepoint Health experienced.  Note: Jason and Carol Ann refer to slides at points of this session; the audio can stand alone but if you prefer you can also download them on the Norwood website (free with registration): https://www.norwood.com/resource/the-roi-of-outpatient-cdi-slide-deck/  

The FDA Group's Nick Capman speaks with Regina Atim, PharmD, pharmacist, maternal and perinatal health advocate, and founder of Clinicians Touch Healthcare Solutions. Regina brings deep expertise at the intersection of clinical practice, regulatory strategy, and maternal health innovation—including work on technologies to detect pregnancy-acquired cardiovascular disease.Their conversation explores FDA/ICH's new E21 draft guidance, Inclusion of Pregnant and Breastfeeding Women in Clinical Trials. Regina explains why pregnant and breastfeeding women have historically been excluded from research, how that has left clinicians and patients with insufficient evidence, and why E21 represents a cultural and scientific shift toward safe, risk-based inclusion.Read the draft guidance here: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e21-inclusion-pregnant-and-breastfeeding-women-clinical-trialsRegina shares practical insights on:How physiologic changes in pregnancy alter drug absorption, distribution, metabolism, and elimination.The dangers of underdosing, overdosing, or avoiding treatment altogether in the absence of trial data.Why clinicians should avoid inappropriate substitutions (e.g., some NSAIDs) and instead rely on evidence-based dosing.How E21 encourages continued monitoring of participants who become pregnant during a trial rather than automatic withdrawal.The stepwise approach to lactation studies—starting with breast milk concentration, then estimating infant dose, and eventually assessing infant exposure and safety.The role of PK/PD modeling, nonclinical data, and real-world evidence in bridging evidence gaps.How sponsors can engage FDA early to align on inclusion triggers and maternal–fetal expertise.About The FDA GroupThe FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations: https://www.thefdagroup.com/

Guest: Le Hua, MD Diagnosing multiple sclerosis (MS) in older patients presents unique challenges, especially as age-related comorbidities and common neurological findings often mimic MS. Hear from Dr. Le Hua as she highlights the importance of thorough clinical history, cautious interpretation of imaging, and the role of paraclinical studies in ensuring accurate MS diagnosis, particularly in patients over 50. Dr. Hua is the Director of Clinical Operations and Director of the Multiple Sclerosis Program at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas. She also spoke about this topic at the 2025 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress.

See omnystudio.com/listener for privacy information.

Guest: Le Hua, MD Diagnosing multiple sclerosis (MS) in older patients presents unique challenges, especially as age-related comorbidities and common neurological findings often mimic MS. Hear from Dr. Le Hua as she highlights the importance of thorough clinical history, cautious interpretation of imaging, and the role of paraclinical studies in ensuring accurate MS diagnosis, particularly in patients over 50. Dr. Hua is the Director of Clinical Operations and Director of the Multiple Sclerosis Program at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas. She also spoke about this topic at the 2025 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress.

Guest: Le Hua, MD Diagnosing multiple sclerosis (MS) in older patients presents unique challenges, especially as age-related comorbidities and common neurological findings often mimic MS. Hear from Dr. Le Hua as she highlights the importance of thorough clinical history, cautious interpretation of imaging, and the role of paraclinical studies in ensuring accurate MS diagnosis, particularly in patients over 50. Dr. Hua is the Director of Clinical Operations and Director of the Multiple Sclerosis Program at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas. She also spoke about this topic at the 2025 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress.

The FDA Group's Nick Capman speaks with Catherine Lunardi, Founder and CEO of GenAIz. With nearly a decade leading GenAIz and prior leadership roles at GSK, CGI, and Héma-Québec, Catherine brings a seasoned perspective on how life science organizations can practically and compliantly deploy AI to build the next generation of labs.Catherine explains the biggest challenges labs face today—like fragmented data, manual processes, and costly compliance reviews—and how AI can help orchestrate data, surface anomalies, and accelerate insights without replacing the people at the center of science. She outlines a step-by-step approach to identifying the right challenges, aligning AI projects with company strategy, piloting solutions with clear ROI, and managing change so teams embrace and sustain new tools.Nick and Catherine also discuss the balance between innovation and regulation, how to keep humans in the loop, and why strong governance and explainability are essential to ensuring AI adds real value in GLP environments.About The FDA Group: The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations: ⁠https://www.thefdagroup.com/

The FDA Group's Nick Capman speaks with Jeff Brenneman, Vice President of Global Operations Quality at Alora Pharmaceuticals. With more than 25 years of pharmaceutical manufacturing experience spanning branded, generic, and OTC products, Jeff brings a deep perspective on sustaining inspection readiness across multiple sites while leading global quality teams.Jeff shares why inspections feel less predictable today—with more variability in inspector experience and a higher likelihood that minor issues become formal observations—and how leaders can respond without overreacting. He explains how to prepare documentation so that it's understandable to any inspector, what makes a quality system truly “robust” in practice, and why culture, accountability, and simplicity matter as much as compliance.Nick and Jeff also explore practical steps for keeping data integrity controls sharp, building efficient systems that don't overburden teams, and fostering engagement so quality is seen as a partner, not just a policing function.About The FDA Group: The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations: https://www.thefdagroup.com/

In this interview, we sit down with John Tobin, Vice President of Clinical Operations at Splice Bio, to explore groundbreaking gene therapy research for Stargardt's disease and its potential impact on the blind and visually impaired community. John shares insights into Splice Bio's mission, how their innovative work could transform options for people living with vision loss, and what families, professionals, and supporters should know about emerging treatments. Stay tuned until the end for information on how to get involved in Splice Bio's clinical trials. Learn more here: www.splice.bio/clinical Or send an email to: Clinicaltrials@splice.bio #SpliceBio #genetherapy #clinicaltrials

The FDA Group's Nick Capman speaks with Marcus Gesner, Vice President of Global Quality at embecta. With more than two decades of leadership experience at companies including Boston Scientific, Olympus, Covidien, JUUL Labs, and others, Marcus brings a unique perspective to what makes a quality organization truly high-performing.Marcus shares why compliance is only the baseline “entry fee” for quality—and how high-functioning teams go further by protecting a company's right to compete, preventing manufacturing and supply disruptions, enabling speed to market, and building trust across the business.He discusses the metrics that matter most (like defect rates, back orders, holds, complaints, and R&D delays), how to structure incentives that drive the right behaviors, and practical strategies for recruiting, onboarding, and retaining people with the drive, courage, and creativity to lead meaningful change.Nick and Marcus also explore how leaders can create the right balance of accountability and innovation, foster collaboration across functions, and ensure quality is seen as a value-driving partner rather than a cost center or policing function.About The FDA Group:The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations: https://www.thefdagroup.com/

Nobody knows ALS better than people living with the disease. Therefore, it’s crucial for scientists to utilize the perspectives of people with lived experience in their research. Earlier this year, ALS TDI joined with Her ALS Story—a group of women diagnosed with ALS before the age of 35—to put on a series of Town Hall webinars that highlighted the importance of this connection. The three-part series featured discussions about ALS risk factors, lesser-known symptoms, and stories of diagnosis. In each session, researchers from ALS TDI’s ALS Research Collaborative, or ARC Study, presented information about our current scientific understanding of each topic, while Her ALS Story members shared their own personal experiences. Today, on Endpoints, we’ll hear some highlights from each episode of the series. We’ll also be joined by Dr. Danielle Boyce, ALS TDI’s Principal Investigator, Real World Evidence, and Alan Premasiri, our Director of Clinical Operations, to discuss what they learned from the discussions and how conversations like these can help shape the way they approach their research. If you'd like to learn more about ALS TDI's research and how we are incorporating lived experience to advance research, consider attending the ALS TDI Summit on October 17th, 2025 in Boston, MA or online. Register here: https://fundraise.als.net/alssummit/Support the show: https://www.als.net/donate/See omnystudio.com/listener for privacy information.

Spontan, intuitiv, ohne Skript, Improvisation pur! Authentisch, ehrlich, direkt! Dafür steht Weissbunt! Prof. Dr. Jalid Sehouli, der Direktor der Frauenklinik an der Charité – Campus Virchow, startete im Mai 2021 mit „WeissBunt“ seinen eigenen Podcast. „Yvonne Ulrich ist Senior Vice President Clinical Development mit langjähriger internationaler Erfahrung in der Leitung globaler klinischer Studien. Sie verantwortete weltweit Clinical Operations, Site Management und Patienteneinbindung und setzte erfolgreich neue digitale Studienportale um, um Zugang und Diversität in klinischen Studien zu fördern. Ihre Expertise umfasst Qualitäts- und Risikomanagement, Patient Advocacy, strategisches Sourcing sowie Budget- und Teamführung. Mit ihrem Engagement trägt sie maßgeblich dazu bei, klinische Entwicklungen effizienter zu gestalten und die Patientenversorgung nachhaltig zu verbessern.“ Prof.Dr. Jalid Sehouli ist renommierter Krebsspezialist, Frauenarzt, Wissenschaftler, Schriftsteller und Weltbürger und engagiert sich seit Jahren für die zivile Gesellschaft für ein ganzheitliches und soziales Miteinander. Der Podcast entstand in Zusammenarbeit mit der Berliner Marketing Agentur Brand Activation und baut Brücken aus der Welt der Medizin in die unterschiedlichsten Bereiche der Gesellschaft. Instagram: @dr.sehouli @brandactivation_berlin Homepage: https://www.brand-activation.de https://weissbunt.podigee.io/ Presseanfragen: Karim Loreti per E-Mail an presse@brand-activation.de Allgemeine Anfragen: per E-Mail an request@brand-activation.de

The FDA Group's Nick Capman sits down with executive consultant Sean Gallimore to break down what makes medtech leaders and teams truly effective. Drawing from decades of experience across medical devices, diagnostics, CROs, and industrial technology, Sean shares his practical framework for leadership—the 4 Cs: Strategic Clarity, Capabilities, Compliance, and Connectedness—and how each one directly impacts growth, culture, and execution.Listeners will learn how to:Pressure-test whether your strategy is actually winnable.Match organizational capabilities to goals (and pivot when they don't).Use KPIs and OKRs to diagnose execution gaps.Build stronger trust and culture through connectedness, from “gemba” walks to multi-channel communication.Sean also shares real-world stories—from transforming an underperforming ultrasound launch to shifting a company's culture from “play not to lose” to “play to win.” Whether you're leading in medtech, life sciences, or beyond, this episode delivers actionable insights you can bring straight back to your team.About the Guest:Sean Gallimore, MBA is an executive consultant with 30 years of leadership across Fortune 500, mid-cap, and private equity–backed companies in medical devices, life sciences, and industrial technology. He has held senior roles at Medtronic, Smith & Nephew, Philips, Parexel, PDI Healthcare, and Dynisco, driving growth through strategy execution, turnarounds, innovation, and building high-performing teams. Today, he advises early-stage medtech companies on scaling operations, commercial strategy, and organizational development.About The FDA Group:The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations: https://www.thefdagroup.com/

(00:00:00) Intro (00:00:32) Welcome Katie Martin, PA-C (00:02:22) How I treat patients and manage operations (00:04:34) How to measure an employee's success (00:05:59) How we decide what treatments to add to our practice (00:08:02) Growth beyond the empire (00:09:48) How training translates into consistency between practices (00:11:50) The value of having good processes in place (00:14:16) Why safety always comes first (00:14:55) Key takeaways about working in aesthetics (00:15:38) Links and outro As the VP of Clinical Operations at Holden Timeless Beauty, Katie Martin, PA-C wears a lot of hats. While seeing patients, she leads the day-to-day operations of a thriving, multi-location medical spa which requires consistency across locations and experienced staff.For Katie, safety and compliance always come first, even in a beauty-forward environment. Her mantra is safety first, beauty second. When it comes to performance management, Katie's team keeps a close eye on metrics like total revenue, revenue per hour, and revenue per visit to gauge each provider's impact.As the business grew to four locations, she learned the challenges of scaling and standardizing clinical care while making sure they never lost the personal touch. About Katie Martin, PA-CKatie Martin, PA-C is a Physician Associate specializing in medical aesthetics since 2015. Her passion is in education — clients, injectors and industry professionals. Katie is the Vice President of Clinical Operations and an advanced injector at HTB Aesthetics in Southern California. As a GAIN trainer for Galderma, she travels the country to train other injectors in safe techniques with natural results. Connect with Katie on LinkedInFollow Katie on Instagram @katie.the.injectorLearn more about Holden Timeless BeautyGuestKatie Martin, PA-C, Vice President of Clinical OperationsHolden Timeless BeautyHostRobin Ntoh, VP of AestheticsNextechPresented by Nextech, Aesthetically Speaking delves into the world of aesthetic practices, where art meets science, and innovation transforms beauty.With our team of experts we bring you unparalleled insights gained from years of collaborating with thousands of practices ranging from plastic surgery and dermatology to medical spas. Whether you're a seasoned professional or a budding entrepreneur, this podcast is tailored for you.Each episode is a deep dive into the trends, challenges, and triumphs that shape the aesthetic landscape. We'll explore the latest advancements in technology, share success stories, and provide invaluable perspectives that empower you to make informed decisions.Expect candid conversations with industry leaders, trailblazers and visionaries who are redefining the standards of excellence. From innovative treatments to business strategies, we cover it all.Our mission is to be your go-to resource for staying ahead in this ever-evolving field. So if you're passionate about aesthetics, eager to stay ahead of the curve and determined to elevate your practice, subscribe to the Aesthetically Speaking podcast.Let's embark on this transformative journey together where beauty meets business.About NextechIndustry-leading software for dermatology, medical spas, ophthalmology, orthopedics, and plastic surgery at https://www.nextech.com/ Follow Nextech on Instagram @nextechglowAesthetically Speaking is a production of The Axis: theaxis.io Theme music: I've Had Enough, Snake City

Send us a textIn this episode of the Life Science Success Podcast my guest is Lauri Befus, Vice President of Clinical Operations at M3 Wake Research, a leading integrated site network in the United States. With over 13 years of experience in clinical research and healthcare operations, Lauri brings a unique perspective to clinical trials, focusing on patient-centric strategies and operational excellence.00:00 Introduction to Life Science Success Podcast00:37 Meet Lauri Befus: Vice President of Clinical Operations at M3 Wake Research00:59 Lauri's Journey into Clinical Research01:53 Educational Background and Early Career02:36 Career Progression and Key Milestones04:25 Challenges in the Life Sciences Industry05:18 Diversity and Inclusion in Clinical Trials06:16 Overview of M3 Wake Research07:37 Lauri's Role and Responsibilities13:59 Innovative Projects and Initiatives16:28 Future Goals and Industry Innovations17:31 Leadership Insights and Advice24:19 Conclusion and Final Thoughts

The FDA Group's Nick Capman sits down with Dr. Manfred Stapff—physician, author, and founder of Candid Advisory Inc., a consultancy specializing in real-world evidence and clinical development—for a wide-ranging conversation about how real-world data is reshaping drug development, regulatory decisions, and public understanding of evidence.Dr. Stapff draws on decades of experience across medical affairs, clinical trials, and RWE analytics to explain why real-world evidence isn't a replacement for randomized controlled trials—but a necessary complement. He outlines how to transform raw data into credible evidence, how the FDA is using RWE today, and why quality, transparency, and context are essential in data-driven science.He also offers cautionary insight on common pitfalls—from bias in training data and misinterpreted statistics to the challenges of AI integration in healthcare research.What they cover:What real-world evidence is (and isn't)—and how it differs from clinical trial dataHow RWE is being used by the FDA to support label expansions and safety monitoringKey risks around self-reported data, upcoding, and poor data qualityWhy statistical significance isn't enough—and how to evaluate clinical relevanceHow AI can accelerate pattern recognition and predictive diagnosticsWhy training data matters—and how bias can infiltrate large-scale AI toolsThe role of educated skepticism in interpreting data-driven claims in both science and societyDr. Manfred Stapff is the founder and principal consultant at a boutique advisory firm focused on real-world evidence strategy, clinical development, and medical data intelligence. He is the author of Real World Evidence Unveiled and a frequent speaker on the role of data integrity, statistical literacy, and AI in advancing medical research. His current work supports life science companies and investors in evaluating drug development strategies, acquisition opportunities, and data-driven innovations.The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus in Quality Assurance, Regulatory Affairs, and Clinical Operations. For project or resource needs, visit ⁠⁠https://www.thefdagroup.com⁠⁠

Navigating the complexities of running a therapy practice today means balancing clinical care with growing administrative demands and emerging technology.Ted Faneuff, a practicing therapist and Head of Clinical Operations at Upheal, joins Michael Fulwiler to explore how AI is reshaping mental health care and helping therapists reclaim time and reduce burnout.Ted shares his personal journey, including his late ADHD diagnosis, and explains how AI-powered tools can support therapists in staying fully present with clients while easing documentation burdens.Listen to this conversation to understand what therapists need to know about AI, data privacy, and ethical adoption (plus why therapist involvement is critical in shaping the future of mental health technology).In the conversation, they discuss:How AI assistants can transform therapy workflows and save hours each weekThe importance of clear consent and privacy standards for AI use in therapyAddressing fears about AI replacing therapists and the role of human validationConnect with the guest:Ted on LinkedIn: https://www.linkedin.com/in/ted-faneuff-lisw-s-lmsw-lcsw-mba-b3030350/ Visit the Upheal website: https://www.upheal.io/ Connect with Michael and Heard:Michael's LinkedIn: https://www.linkedin.com/in/michaelfulwiler/ Newsletter: https://www.joinheard.com/newsletter Book a free consult: joinheard.com/consult Jump into the conversation:(00:00) Welcome to Heard Business School(00:34) Meet Ted Faneuff (01:20) Exploring How AI Can Support Therapy and Mental Health Care(02:19) Breaking Down What Artificial Intelligence Really Means(04:15) A Simple Explanation of Generative AI(06:58) How Large Language Models Power Today's AI Tools(10:07) Addressing the Privacy Concerns That Come with AI(11:02) What Therapists Need to Know About HIPAA and SOC 2 Security(13:06) Why Getting Clear Consent Matters When Using AI(14:45) The Debate on Whether AI Could Ever Replace Therapists(17:21) Looking at AI's Ability to Show Empathy and Build Trust(19:38) How AI Can Lend a Hand and Ease Therapist Workloads(27:47) Why It's Important for Therapists to Help Guide AI Development(35:54) What to Look for When Choosing AI Tools for Your Practice(44:23) How AI Might Expand Access and Help Therapists Stay in the FieldThis episode is to be used for informational purposes only and does not constitute legal, business, or tax advice. Each person should consult their own attorney, business advisor, or tax advisor with respect to matters referenced in this episode.

This episode features Dr. Benjamin J. Pieters, Pediatric Anesthesiologist and Vice Chair of Clinical Operations at Children's Mercy Kansas City, discussing major trends in anesthesiology, including workforce shortages, private equity involvement, and evolving employment models. He shares how his team is leveraging data, evidence-based care, and leadership development to shape the future of pediatric anesthesia and healthcare delivery.

Join Dr. Stephanie on Converge Autism Radio with special guest Courtney Lasky, M.Ed., BCBA, LBA and PhD candidate, as they unpack the real-world impact of Applied Behavior Analysis (ABA) in autism. Courtney shares insights from her 10+ years leading compassionate, trauma-informed clinical teams at ABS Kids, explores common myths, highlights crucial components of effective ABA care, and reveals how leadership strategies can foster psychological safety in therapy settings. Whether you're a caregiver, clinician, or advocate, this episode offers fresh perspectives and practical guidance to support autistic individuals and their families with dignity and expertise.About the speaker: Courtney Lasky, M.Ed., BCBA, LBA Courtney Lasky is a Board Certified Behavior Analyst (BCBA) amd PhD candidate with over a decade of experience in Applied Behavior Analysis (ABA). As the Director of Clinical Operations for ABS Kids, she leads clinical teams in providing high-quality, compassionate care to children and families.Recognized as a subject matter expert, Courtney has been featured on Crime Stories with Nancy Grace and the Dr. Drew Podcast, where she shares her insights on behavior analysis and its broader applications. She is passionate about leadership, staff training, and fostering psychological safety within clinical teams.Beyond her professional work, Courtney is a dedicated wife and mother of six, living in Irmo, South Carolina. Balancing a thriving career with a full and adventurous family life, she brings both expertise and heart to everything she does.

The FDA Group's Nick Capman sits down with Dr. Kimberly Garko, Chief Technical Officer and 25-year life science veteran, for a deep dive into one of the most misunderstood concepts in the industry: the cost of quality.Dr. Garko shares why quality should be viewed not as a cost center but as a strategic investment—and how companies can embed that mindset into their culture, systems, and leadership practices. She outlines the difference between good and poor quality costs, explains how to build ROI-focused metrics, and offers practical ways to foster transparency, psychological safety, and proactive decision-making.From regulatory intelligence and scorecard design to audit readiness and AI integration, this conversation is packed with insights for quality leaders and executive teams alike.What they cover:How to shift your organization's mindset from compliance to value creationThe real financial and operational impact of poor vs. proactive qualityHow to build scorecards, systems, and reporting processes that drive actionWhy culture, transparency, and psychological safety are core to sustainable qualityPractical approaches to audit readiness, supplier oversight, and training_____The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus in Quality Assurance, Regulatory Affairs, and Clinical Operations. For project or resource needs, visit ⁠⁠https://www.thefdagroup.com/

This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Michael Bottros, Clinical Operations Chief and Medical Director for Pain Services, Department of Anesthesiology, Keck School of Medicine of USC. He shares key trends in non-opioid pain management, the shift toward curative procedures, and how innovation, workforce investment, and care path efficiency are shaping the future of outpatient spine and orthopedic care.

This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Michael Bottros, Clinical Operations Chief and Medical Director for Pain Services, Department of Anesthesiology, Keck School of Medicine of USC. He shares key trends in non-opioid pain management, the shift toward curative procedures, and how innovation, workforce investment, and care path efficiency are shaping the future of outpatient spine and orthopedic care.

This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Michael Bottros, Clinical Operations Chief and Medical Director for Pain Services, Department of Anesthesiology, Keck School of Medicine of USC. He shares key trends in non-opioid pain management, the shift toward curative procedures, and how innovation, workforce investment, and care path efficiency are shaping the future of outpatient spine and orthopedic care.

Nick Capman talks with Marcia Baroni—a microbiologist with 27 years in global pharma-quality leadership—about reframing quality from a controllable expense to a strategic asset. Baroni contrasts “bad-quality” costs (scrap, recalls, deviations) with “good-quality” investments (testing, preventive controls, oversight) and explains why the latter pay for themselves in resilience and brand value. She illustrates the stakes with a $600 million nationwide OTC-drug recall caused by chemically treated pallets—an error frontline staff flagged but a weak quality culture ignored. The conversation dives into building psychological safety and metrics that drive the right behaviors, not under-reporting, shifting quality from “policing” to cross-functional partnership, and practical first steps executives can take to gauge their current maturity and start investing for future yield._____The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus in Quality Assurance, Regulatory Affairs, and Clinical Operations. For project or resource needs, visit ⁠⁠https://www.thefdagroup.com/

Central Virginia Health Services knows how crucial it is to automate tasks at scale. According to Kimberly Ferguson, Director of Clinical Operations, their community health centers treat one-third of all Virginia residents, some 46,000 users per year. In this video, Ferguson describes how the Sunoh.ai medical scribe helps their physicians become more productive, form more patient relationships, and reduce burn-out.One of the most interesting things Ferguson did when implementing Sunoh.ai was to leverage an after hours work report from their eClinicalWorks EHR.  This report more commonly known as the "pajama time" report showed when clinicians were working and what they were working on.  After-hours use ("pajama time") was very high when they began, and most of this overtime was spent entering documentation.  Ferguson and the team leveraged this report to identify who could benefit the most from Sunoh.ai.  Plus, they used it to track how after hours work changed after implementing Sunoh.ai.Learn more about Central Virginia Health Services: https://www.cvhsinc.org/Learn more about eClinicalWorks: https://www.eclinicalworks.com/Learn more about Sunoh.ai: https://sunoh.ai/Healthcare IT Community: https://www.healthcareittoday.com/

In this episode, Jonathan Norman (Director, Localisation Services, YPrime) and Laura Russell (Senior Vice President, Head of Data and AI Product Development, Advarra) join the podcast to discuss how artificial intelligence is transforming today's clinical operations. They dive deeper into how AI can be used to improve protocol design, drive efficiency in localization processes, and modernize clinical operations to expand access to trials and get treatments to patients sooner. 

Dr. Stephanie discusses ABA and Autism with Converge Autism Summit speaker Courtney Lasky, PHD candidate. About the speaker: Courtney Lasky, M.Ed., BCBA, LBA Courtney Lasky is a Board Certified Behavior Analyst (BCBA) amd PhD candidate with over a decade of experience in Applied Behavior Analysis (ABA). As the Director of Clinical Operations for ABS Kids, she leads clinical teams in providing high-quality, compassionate care to children and families.Recognized as a subject matter expert, Courtney has been featured on Crime Stories with Nancy Grace and the Dr. Drew Podcast, where she shares her insights on behavior analysis and its broader applications. She is passionate about leadership, staff training, and fostering psychological safety within clinical teams.Beyond her professional work, Courtney is a dedicated wife and mother of six, living in Irmo, South Carolina. Balancing a thriving career with a full and adventurous family life, she brings both expertise and heart to everything she does.

Nicholas Capman of The FDA Group welcomes David Marlin, Co-Founder and CEO of Metacomet Systems, to explore the often-overlooked complexities of royalty management in life sciences.Drawing from his experience helping over 200 companies automate royalty payouts, David explains how biotech, pharma, and medical device firms struggle to manage licensing agreements as they scale. What starts as a simple once-a-year payment can quickly evolve into a tangled web of tiered rates, stacked IP, country-specific rules, and audit requirements.David breaks down where companies most often go wrong—managing rules in Excel, underestimating the operational burden, and lacking traceability across contracts, SKUs, and sales data. He discusses how automation not only reduces risk and effort but also preserves trust with licensors by ensuring accuracy and transparency.The conversation also covers how organizations can recognize when it's time to move beyond spreadsheets, what a successful royalty system implementation looks like, and why experience matters in such a niche space.Whether you're paying or receiving royalties, this episode offers valuable insight into a critical but often misunderstood area of life sciences operations._____The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus in Quality Assurance, Regulatory Affairs, and Clinical Operations. For project or resource needs, visit ⁠https://www.thefdagroup.com/

Send us a textSchedule an Rx AssessmentPill bottles don't talk...but what if they could? Now you can know exactly how (and when) patients take their meds.That's the power of Remote Therapeutic Monitoring!And on this week's episode of The Bottom Line Pharmacy Podcast, we're diving into the mechanics of Remote Therapeutic Monitoring.Bonnie Bond, CPA, and Austin Murray sit down with Jen Whalen, Director of Clinical Operations at MedSense, and Matt Gilbert, VP of Business Transformation at RxSafe/Eyecon to explore:- Remote Therapeutic Monitoring as a New, Billable Revenue Stream- How real-time adherence tracking works with any packaging- Long-term Care Layering and How MedSense Fits right in- Reducing Workload While Increasing Patient InsightJoin the discussion with us!Click here for the transcript.Stay connected with Medsense and RxSafe:Jennifer Whalen LinkedInMatthew Gilbert LinkedInMedsense WebsiteMedsense LinkedInRxSafe WebsiteRxSafe LinkedInRxSafe InstagramRxSafe YouTubeStay connected with us:  FacebookTwitter (X)LinkedIn InstagramScotty Sykes – CPA, CFP LinkedIn Scotty Sykes – CPA, CFP Twitter More resources on this topic:Podcast | Driving Independent Pharmacy Profitability in 2025Podcast | Transforming Your Pharmacy: Supplements, Strip Packaging, and PBM ReformPodcast | Tradeshow Series: AtriumX, Telehealth, Functional Medicine

In this episode of the Innovation series, Dr. Parikh is back discussing virtual care platforms. Today he interviews Dr. Sahil Patel, gastroenterologist and Medical Director for SideBy Care, and Norah Candito, registered dietician and Director of Clinical Operations for SideBy Care. They discuss the origin of SideBy Care and delve into its mission to help patients with disorders of the gut-brain interaction. 

In this episode of Positive Philter, Philip reconnects with high school friend Dr. Haley Parker, the Director of Clinical Operations and Professor at Virginia University of Integrative Medicine. Haley shares her inspiring journey from studying Anthropology and Religious Studies to embracing Eastern Medicine and Acupuncture. Together, they explore the importance of a holistic approach to healing—one that nurtures the mind, body, and spirit—and how it complements Western healthcare practices. Haley also reflects on her commitment to cultural humility, discussing how her broader worldview shapes her work as a healer and advocate for integrative medicine. Shout Outs and Plugs Website for VUIM: https://www.vuimclinic.com/ VUIM's Instagram Page: https://www.instagram.com/vuimclinic/ VUIM's LinkedIn Page: https://www.linkedin.com/company/vuimedu/ Dr. Haley's Instagram: https://www.instagram.com/dr.haley.vuim/ Dr. Haley's LinkedIn Page: https://www.linkedin.com/in/haley-parker-vuim/ If you have a question for the podcast call 571-336-6560 or leave a question via this Google Form. Five Minute Journal by Intelligent Change Affiliate Code: https://www.intelligentchange.com/?rfsn=4621464.017186 Tappy Card “Electronic Business Card” Affiliate Code:  https://tappycard.com?ref:philip-wilkerson Please leave a rating/review of the Podcast https://lovethepodcast.com/positivephilter Intro music provided by DJ BIGyoks. Check out his Instagram and Soundcloud channel here:  https://www.instagram.com/beats.byyoks/ https://soundcloud.com/dj-bigyoks Outro music provided by Ryan Rosemond. Check out his Soundcloud channel here: https://soundcloud.com/brothersrosemond/albums  Purchase "Forty Years of Advice" by Philip Wilkerson: https://a.co/d/2qYMlqu Leave Your Feedback by filling out this audience survey: https://forms.gle/ncoNvWxMq2A6Zw2q8 Sign up for Positive Philter Weekly Newsletter: http://eepurl.com/g-LOqL Please follow Positive Philter: Positive Philter Facebook Page Positive Philter Twitter Positive Philter Instagram  If you would like to support the podcast, please consider donating to the Positive Philter Patreon page: https://www.patreon.com/positivephilter Positive Philter was selected by FeedSpot as Top 20 Positive Thinking Podcasts on the web. https://blog.feedspot.com/positive_thinking_podcasts/ Jeff's Anti-Hunger Fund The Positive Philter Podcast is dedicated to Jeff Kirsch. A long-time supporter of the show and a major influence on this show's growth. Please support the careers of future advocates by donating to the Jeff Kirsch Fund for Anti-Hunger Advocacy. This fund was named after Jeff Kirsch for his decades of service in fighting hunger and inequality. Link to fund: https://frac.org/kirschfund Pats for Patriots  If you are a member of the #MasonNation, please consider sending a Pats for Patriots. Pats for Patriots are a free and easy way to thank, recognize, show appreciation for a Mason colleague or student who has taken the time to do something kind, generous or thoughtful towards others. For more information, visit: https://forms.office.com/r/HRZGvhdJEA We have received more than 2,000 nominations from the Mason community so far. Keep those nominations coming in!  

In this episode of Equity Actions, James Burroughs engages in a compelling conversation with Yinka Ajose, Senior Director of Clinical Operations, and Tonya Montesinos, Senior Director of Clinical Practice. Together, they explore the importance of advocating for equitable roles among staff, providing essential resources to patients and families, and gaining a deeper understanding of community needs.

In this episode, we discuss the psychological effects of interacting with AI chatbots like ChatGPT, Google's Gemini, Microsoft's Copilot, and others. We are joined by Dr. Sidharth Chowdhury, Neuropsychiatrist and the Vice President of Clinical Operations at Rxmen, and Ankita Chakravarti, Deputy News Editor, Moneycontrol. Tune in.

In this episode of The Clinical Research Coach, host Leanne Woehlke sits down with Robert Goldman, Head of Clinical Operations at Contraline, a company pioneering innovation in reproductive health. Robert is a true industry disruptor, challenging traditional clinical trial models by integrating AI, decentralized trial frameworks, and real-time data analytics to accelerate timelines and improve patient outcomes.Robert shares his journey into clinical research, the challenges he's faced while introducing disruptive models, and his vision for the future of clinical operations. He also offers practical advice for clinical leaders looking to embrace innovation and transform the patient experience.If you're ready to explore how technology and human-centered design are shaping the future of clinical trials, this is an episode you don't want to miss!To learn more:Robert Goldman is the Head of Clinical Trail Operations at Contraline as well as the Founder of ALCOA Consulting. https://www.linkedin.com/in/robert-s-goldman-358b0868/

According to our guest on this week's episode of the Faculty Factory Podcast, John Heymann, MD, every academic medicine professional can bet big on two things: compassion and understanding. Dr. Heymann is a neuroradiologist at the University of Texas Medical Branch (UTMB) in Galveston, where he serves as an Associate Professor in Radiology, as well as the Director of Residency Programs and Vice Chair of Clinical Operations. “Being angry all the time is not conducive to longevity, and I think a lot of that comes from misunderstanding other people and their mind states. Therefore, it's important to be mindful and practice compassion,” Dr. Heymann said. It truly might be time to double down on compassion. Understanding is at the core of compassion, as we learn in this discussion, and both elements are necessary for compassion to manifest. The bottom line is that how we interact with one another and recognize each other's challenges is an essential part of our mental health and well-being. Visit the Faculty Factory website for more resources:  https://facultyfactory.org/

In this episode, Maura Nazario, MSN, RN, SANE, Vice President of Clinical Operations for Home-Based Services & Hospital at Home at AdventHealth, discusses the organization's commitment to delivering whole-person care beyond traditional hospital walls. She shares insights on scaling hospital-at-home programs, leveraging technology for better patient outcomes, and ensuring personalized, high-quality care that aligns with AdventHealth's mission.

In this powerful episode, Dr. Jake Taylor Jacobs, President & COO of SIPS Healthcare, is joined by Sharon Green-Golden, Director of Clinical Compliance, and Derek Jones, Director of Clinical Operations, to tackle some of the toughest challenges facing sterile processing professionals today.

SPD 911 – The Pay Problem, Staffing Challenges & The Future of Sterile Processing (Part 1) In this powerful episode, Dr. Jake Tayler Jacobs, President & COO of SIPS Healthcare, is joined by Sharon Green-Golden, Director of Clinical Compliance, and Derek Jones, Director of Clinical Operations, to tackle some of the toughest challenges facing sterile processing professionals today.

Marci Strauss, PharmD, Manager, Clinical Operations at Pharmacy First talks about medication adherence and clinical services in 2025 and what expectations and opportunities are available for pharmacies this year.Podcast Host Nick Dorich, PharmD, PQS Senior Manager of Pharmacy Accounts, asks Strauss about revenue generating clinical services programs, continuous quality improvement, and how to prioritize these programs throughout 2025. Strauss recommends the pharmacist work with staff to understand contracts, review patient outreach and communications, and leverage appointment based models.https://www.pharmacyfirst.com/

Listen to Longevity Leadership Conference coverage. In this episode, Adam Torres interviews  Ahmed Omar, Founder of Sully.ai, explore Sully.ai at the Longevity Leadership Conference.  Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia

Discover the transformative shifts in the dental industry with our special guest, Dr. AJ Acierno, President of Clinical Operations at Smile Brands. As the dental field grapples with post-pandemic challenges like workforce shortages and financial pressures, Dr. Acierno shares his insights on maintaining access to care and achieving financial stability for dental practices. Listen in to learn how a provider-centric approach, emphasizing clinical and operational excellence, can help navigate these turbulent times. We explore the strategies Smile Brands employs to integrate new team members and improve patient flow, ensuring that clinical staff aren't overwhelmed.Understanding the patient journey has never been more crucial, especially within Dental Support Organizations. Our conversation with Dr. Acierno reveals how clear expectations and Standard Operating Procedures can enhance the patient experience and uphold high clinical standards. We also delve into the comparative advantages of group practices over private practices and offer practical advice on safeguarding professional standards through contracts. Lastly, we spotlight the importance of networking and open communication in the dental community, providing resources and connections through Smile Brands to support practice growth and collaboration.If you need help finding the perfect location or your ready to invest in commercial real estate, email us at admin@leadersre.com Sign up for a FREE vulnerability analysis and lease renewal services View our library on apple podcasts or REUniversity.org. Connect on Facebook. Commercial Real Estate Secrets is ranked in the top 50 podcasts on real estate

I am delighted to have Kara Collier joining me for the third time today. The last time we connected was in episode 285. Kara is a registered nutritionist and dietitian. As the co-founder and Vice President of Clinical Operations at Nutrisense, she is the leading authority on continuous glucose monitoring technology for health optimization, disease prevention, and reversing metabolic dysfunction. In our discussion today, we dive into the outdated history of dietitian recommendations, the problem with rigid nutritional dogma, and the need for dietary nuances. We look at scale-related phobias and how many individuals have become disconnected from their bodies, and we discuss the use of tools and data for better health. We also share signs of blood sugar dysregulation, explain what blood sugar spikes mean for your health, explore how perimenopause and menopause affect insulin sensitivity, and touch on the benefits of postprandial excursions and training, stressors, macros, and more. I know you will love today's invaluable and insightful conversation with Kara Collier. IN THIS EPISODE YOU WILL LEARN: How dietary advice must fit individual nuances and needs   The dangers of rigid nutritional dogmatism   Why the scale is not a reliable tool for monitoring health The benefits of continuous glucose monitors for analyzing metabolic health How attuning to body signals allows people to make better health decisions Common symptoms of blood sugar dysregulation How the menstrual cycle affects insulin sensitivity and blood glucose levels The impact of various types of exercise on blood glucose levels Will hormetic stress lead to optimal health? The benefits of making protein a dietary priority Connect with Cynthia Thurlow   Follow on Twitter Instagram LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Connect with Kara Collier On social media: karacollierrd or Nutrisenseio Nutrisense Previous Episode Mentioned: Ep. 285 Improving Metabolic Health: Lifestyle Interventions To Optimize Metabolic Health with Kara Collier

Have you ever had something, someone, or even just a conversation light a FIRE in you?   It's as if every nerve in your being is telling you, ‘Hey, this might be the missing piece you've been looking for that you need to try now—okay?'   Well, as a functional medicine practitioner, the insight and transformation that feeling can bring is pure magic.   So, if you're ready to be part of a conversation that's all about pain management, reducing stress, and the beautiful way acupuncture can support your body, then you simply can't miss this episode with Director of Clinical Operations at VUIM Clinic, Dr. Haley Parker.   Click play to hear all of this and…   (00:00:39) Introduction of Dr. Haley and her journey to becoming an acupuncturist.   (00:03:26) How acupuncture works and its effects on the body's healing processes.   (00:06:31) How acupuncture can help retrain the brain and nervous system specifically with fear of movement.   (00:10:23) The impact of modern lifestyle on health and body imbalances.   (00:11:21) How stress affects digestion and overall health.   (00:15:01) Dr. Haley's perspective on smart watches and their potential impact on health.   (00:20:36) The benefits of acupuncture for pregnancy and postpartum recovery.   (00:26:17) Using acupuncture to address infertility and support the overall wellness of both partners in a relationship.   (00:28:52) A natural alternative to botox.   (00:31:21) Dr. Haley's perspective on beauty and anti-aging.   (00:32:51) How acupuncture helps with pelvic floor health, incontinence, and enhancing pelvic floor function.   (00:36:57) The concept of Yin and Yang in Chinese medicine.   (00:39:55) How often should you be getting acupuncture treatments.   (00:42:12) Teaching acupuncture practitioners and the growing field of integrative medicine.   For full show notes, visit ericaziel.com/blog/319

Talking all things pelvic floor, physical therapy, and overall health with the great and powerful Dr. Carrie Yaeger. Carrie is a PT, DPT, Certified Pelvic Rehabilitation Practitioner who also serves as the Regional Director of Clinical Operations at Spooner Physical Therapy. She believes in treating the whole person and considering all aspects of the patient's health to most effectively help them return to optimal function. She is an amazing human you guys will love the episode. You can learn more about Carrie HERE and on IG Love our Content? Drop us a quick review ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠CLICK HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ FREE Week Trial of Our APP ⁠⁠⁠⁠⁠⁠⁠⁠⁠CLICK HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠ Built Different Mastermind Community ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠CLICK HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Want to talk more? Schedule a Call with Me: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Thanks to our Sponsors: My Creatine & Coffee Code JSF for 10% off ⁠⁠⁠⁠⁠⁠⁠CLICK HERE⁠⁠⁠⁠⁠⁠⁠ AG1 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.DrinkAG1.com/jeremyscott⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Free year supply of vitamin D3 with 5 free travel packs or want a FREE sample? Shoot us a DM and ask! Sleeves Sold Separately My Workout Gear -  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://sleevessoldseparately.com/collections/jscott⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Code JSCOTT15 for 15% off all clothes & gear Jaylab Pro Our Protein, Turmeric, Collagen, Krill Oil - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://jeremyscottfitness.jaylabpro.com/products.html⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Code JSF40 for 40% off Collagen if you wish to try it. Dry Farms Wine - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠dryfarmwines.com/jeremyscottfitness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Each new member will earn an extra bottle for just a penny with their first order of wine when they use this link.